Cardinal Health INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Cardinal Health, Inc. announced a 14% revenue increase to $254.2 billion and a 30% rise in non-GAAP operating earnings to $3.6 billion for fiscal year 2026.
NYSE
Cardinal Health reports significant earnings growth in fiscal 2025, driven by strategic acquisitions and specialty pharmaceutical sales, despite a revenue dip from contract expirations.
NYSE
Cardinal Health's fiscal year 2024 performance showcased robust revenue growth, driven by increased demand in branded and specialty pharmaceuticals, despite the expiration of key contracts and ongoing industry challenges.